Søgeresultater - Gomez, Erica
- Showing 1 - 15 results of 15
-
1
-
2
Exploring Molecular and Electronic Property Predictions of Reduced Graphene Oxide Nanoflakes via Density Functional Theory af Gómez, Erica Valencia, Ramírez Guarnizo, Nathalia A., Perea, Jose Dario, López, Alberto Sánchez, Prías-Barragán, Jhon J.
Udgivet 2022Text -
3
Tetrahydrocannabinol Reduces Hapten-Driven Mast Cell Accumulation and Persistent Tactile Sensitivity in Mouse Model of Allergen-Provoked Localized Vulvodynia af Boo, Beebie, Kamath, Rohit, Arriaga-Gomez, Erica, Landry, Jasmine, Emanuel, Elizabeth, Joo, Sookyong, Saldías Montivero, Marietta, Martinov, Tijana, Fife, Brian T., Chatterjea, Devavani
Udgivet 2019Text -
4
-
5
ACTR-13. EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFICATION RATES OBSERVED IN SCREENING PATIENTS FOR RANDOMIZED CLINICAL TRIALS IN GLIOBLASTOMA af van den Bent, Martin, Roberts-Rapp, Lisa A, Ansell, Peter J, Lee, James, Looman, Jim, Bain, Earle, Ocampo, Christopher, Holen, Kyle D, Gomez, Erica J, Lassman, Andrew B
Udgivet 2017Text -
6
Repeated dermal application of the common preservative methylisothiazolinone triggers local inflammation, T cell influx, and prolonged mast cell-dependent tactile sensitivity in mi... af Kline, Jaclyn M., Arriaga-Gomez, Erica, Yangdon, Tenzin, Boo, Beebie, Landry, Jasmine, Saldías-Montivero, Marietta, Neamonitaki, Nefeli, Mengistu, Hanna, Silverio, Sayira, Zacheis, Hayley, Pasha, Dogukan, Martinov, Tijana, Fife, Brian T., Chatterjea, Devavani
Udgivet 2020Text -
7
Repeated Vaginal Exposures to the Common Cosmetic and Household Preservative Methylisothiazolinone Induce Persistent, Mast Cell-Dependent Genital Pain in ND4 Mice af Arriaga-Gomez, Erica, Kline, Jaclyn, Emanuel, Elizabeth, Neamonitaki, Nefeli, Yangdon, Tenzin, Zacheis, Hayley, Pasha, Dogukan, Lim, Jinyoung, Bush, Susan, Boo, Beebie, Mengistu, Hanna, Kinnamon, Ruby, Shields-Cutler, Robin, Wattenberg, Elizabeth, Chatterjea, Devavani
Udgivet 2019Text -
8
Tumor volumes as a predictor of response to the anti-EGFR antibody drug conjugate depatuxizumab mafadotin af Gan, Hui K, Parakh, Sagun, Lassman, Andrew B, Seow, Aidan, Lau, Eddie, Lee, Sze Ting, Ameratunga, Malaka, Perchyonok, Yuliya, Cao, Diana, Burvenich, Ingrid J G, O’Keefe, Graeme J, Rigopoulos, Angela, Gomez, Erica, Maag, David, Scott, Andrew M
Udgivet 2021Text -
9
PATH-29. MOLECULAR DETERMINANTS ASSOCIATED WITH RESPONSE AND RESISTANCE TO DEPATUXIZUMAB MAFODOTIN (ABT-414) IN PATIENTS WITH RECURRENT GLIOBLASTOMA af Lassman, Andrew, Roberts-Rapp, Lisa, He, Lei, Lu, Xin, van den Bent, Martin, Papadopoulos, Kyriakos, Merrell, Ryan, Kumthekar, Priya, Reardon, David, Gomez, Erica, Fischer, JuDee, Jiang, Fang, Zha, Zheng, Bhathena, Anahita, Holen, Kyle, Ansell, Peter, Gan, Hui K, Scott, Andrew
Udgivet 2017Text -
10
ET-19 A PHASE 1 STUDY EVALUATING ABT-414 WITH TEMOZOLOMIDE (TMZ) OR CONCURRENT RADIOTHERAPY (RT) AND TMZ IN GLIOBLASTOMA (GBM) af Gan, Hui K., Fichtel, Lisa, Lassman, Andrew B., Merrell, Ryan, van den Bent, Martin, Kumthekar, Priya, Scott, Andrew M., Pedersen, Michelle, Gomez, Erica, Fischer, JuDee, Ames, William, Xiong, Hao, Dudley, Matt, Munasinghe, Wijith, Roberts-Rapp, Lisa, Ansell, Peter, Holen, Kyle, Reardon, David A.
Udgivet 2014Text -
11
Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma af Reardon, David A., Lassman, Andrew B., van den Bent, Martin, Kumthekar, Priya, Merrell, Ryan, Scott, Andrew M., Fichtel, Lisa, Sulman, Erik P., Gomez, Erica, Fischer, JuDee, Lee, Ho-Jin, Munasinghe, Wijith, Xiong, Hao, Mandich, Helen, Roberts-Rapp, Lisa, Ansell, Peter, Holen, Kyle D., Gan, Hui K.
Udgivet 2017Text -
12
Comparison of Biomarker Assays for EGFR: Implications for Precision Medicine in Patients with Glioblastoma af Lassman, Andrew B., Roberts-Rapp, Lisa, Sokolova, Irina, Song, Minghao, Pestova, Ekaterina, Kular, Rupinder, Mullen, Carolyn, Zha, Zheng, Lu, Xin, Gomez, Erica, Bhathena, Anahita, Maag, David, Kumthekar, Priya, Gan, Hui K., Scott, Andrew M., Guseva, Maria, Holen, Kyle D., Ansell, Peter J., van den Bent, Martin J.
Udgivet 2019Text -
13
Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma af Gan, Hui K, Reardon, David A, Lassman, Andrew B, Merrell, Ryan, van den Bent, Martin, Butowski, Nicholas, Lwin, Zarnie, Wheeler, Helen, Fichtel, Lisa, Scott, Andrew M, Gomez, Erica J, Fischer, JuDee, Mandich, Helen, Xiong, Hao, Lee, Ho-Jin, Munasinghe, Wijith P, Roberts-Rapp, Lisa A, Ansell, Peter J, Holen, Kyle D, Kumthekar, Priya
Udgivet 2018Text -
14
Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study af van den Bent, Martin, Gan, Hui K., Lassman, Andrew B., Kumthekar, Priya, Merrell, Ryan, Butowski, Nicholas, Lwin, Zarnie, Mikkelsen, Tom, Nabors, Louis B., Papadopoulos, Kyriakos P., Penas-Prado, Marta, Simes, John, Wheeler, Helen, Walbert, Tobias, Scott, Andrew M., Gomez, Erica, Lee, Ho-Jin, Roberts-Rapp, Lisa, Xiong, Hao, Bain, Earle, Ansell, Peter J., Holen, Kyle D., Maag, David, Reardon, David A.
Udgivet 2017Text -
15
Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial af Lassman, Andrew B, van den Bent, Martin J, Gan, Hui K, Reardon, David A, Kumthekar, Priya, Butowski, Nicholas, Lwin, Zarnie, Mikkelsen, Tom, Nabors, Louis B, Papadopoulos, Kyriakos P, Penas-Prado, Marta, Simes, John, Wheeler, Helen, Walbert, Tobias, Scott, Andrew M, Gomez, Erica, Lee, Ho-Jin, Roberts-Rapp, Lisa, Xiong, Hao, Ansell, Peter J, Bain, Earle, Holen, Kyle D, Maag, David, Merrell, Ryan
Udgivet 2019Text